These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 32859168)

  • 21. Ocular myasthenia gravis: response to long-term immunosuppressive treatment.
    Sommer N; Sigg B; Melms A; Weller M; Schepelmann K; Herzau V; Dichgans J
    J Neurol Neurosurg Psychiatry; 1997 Feb; 62(2):156-62. PubMed ID: 9048716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous immunoglobulin for prophylaxis of acute exacerbation in Myasthenia Gravis.
    Sorgun MH; Sener HO; Yucesan C; Yucemen N
    Neurol Sci; 2014 Jun; 35(6):891-6. PubMed ID: 24399309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subcutaneous Immunoglobulin Therapy in the Chronic Management of Myasthenia Gravis: A Retrospective Cohort Study.
    Bourque PR; Pringle CE; Cameron W; Cowan J; Chardon JW
    PLoS One; 2016; 11(8):e0159993. PubMed ID: 27490101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An update on the use of immunoglobulins as treatment for myasthenia gravis.
    Alcantara M; Barnett C; Katzberg H; Bril V
    Expert Rev Clin Immunol; 2022 Jul; 18(7):703-715. PubMed ID: 35639497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Case Report: Orbital Myositis and Myasthenia Gravis as Symptoms of Immune Reconstitution Inflammatory Syndrome in a Patient With Human Immunodeficiency Virus Infection.
    Wang Y; Zhao N; Yang J; Wen Y
    Front Immunol; 2020; 11():595068. PubMed ID: 33381117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Juvenile Generalized Myasthenia Gravis: Presented as Unilateral Blepharoptosis and Successfully Managed with Pulse Intravenous Methylprednisolone.
    Poudel P; Anand A; Ghosh S
    Kathmandu Univ Med J (KUMJ); 2021 Jul-Sept.; 19(75):402-407. PubMed ID: 36254435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Myasthenic crisis caused by azathioprine-induced fever].
    Tumani H; George A; Nau R
    Nervenarzt; 1997 Apr; 68(4):336-8. PubMed ID: 9273463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IVIg in myasthenia gravis, Lambert Eaton myasthenic syndrome and inflammatory myopathies: current status.
    Illa I
    J Neurol; 2005 May; 252 Suppl 1():I14-8. PubMed ID: 15959667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Real-world utilization patterns of intravenous immunoglobulin in adults with generalized myasthenia gravis in the United States.
    Qi CZ; Hughes T; Gelinas D; Li Y; Goyal A; Brauer E; Bhuwalka A; Sato M; Jadhav S; Phillips G
    J Neurol Sci; 2022 Dec; 443():120480. PubMed ID: 36347174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myasthenia gravis crisis.
    Bershad EM; Feen ES; Suarez JI
    South Med J; 2008 Jan; 101(1):63-9. PubMed ID: 18176295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous immunoglobulin for myasthenia gravis.
    Gajdos P; Chevret S; Toyka K
    Cochrane Database Syst Rev; 2003; (2):CD002277. PubMed ID: 12804431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Myasthenia gravis].
    Tanaka K
    Nihon Rinsho; 2004 May; 62 Suppl 5():580-5. PubMed ID: 15197988
    [No Abstract]   [Full Text] [Related]  

  • 33. Myasthenia gravis masquerading as acute stroke: a case report.
    Menon SMR; Mokkath NR
    Pan Afr Med J; 2020; 37():305. PubMed ID: 33654524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term effect of intravenous immunoglobulin on anti-MuSK antibody-positive myasthenia gravis.
    Shibata-Hamaguchi A; Samuraki M; Furui E; Iwasa K; Yoshikawa H; Hayashi S; Yamada M
    Acta Neurol Scand; 2007 Dec; 116(6):406-8. PubMed ID: 17986100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mycophenolate mofetil - as an adjunctive immunosuppressive therapy in refractory myasthenia gravis: The Singapore experience.
    Prakash KM; Ratnagopal P; Puvanendran K; Lo YL
    J Clin Neurosci; 2007 Mar; 14(3):278-81. PubMed ID: 16597503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recovery from myasthenic crisis after use of IVIG therapy.
    Jain K; Passi GR; Rajguru M; Athle S; Gandhi DM
    Indian Pediatr; 1998 Sep; 35(9):901-3. PubMed ID: 10216601
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of IVIg and PLEX in patients with myasthenia gravis.
    Barth D; Nabavi Nouri M; Ng E; Nwe P; Bril V
    Neurology; 2011 Jun; 76(23):2017-23. PubMed ID: 21562253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thromboembolic complications following intravenous immunoglobulin therapy in immune-mediated neurological disorders.
    Chun W; Kim Y; Park SH; Choi SJ
    J Clin Neurosci; 2021 Aug; 90():311-316. PubMed ID: 34275568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase 2 trial in acetylcholine receptor antibody-positive myasthenia gravis of transition from intravenous to subcutaneous immunoglobulin: The MGSCIg study.
    Pasnoor M; Bril V; Levine T; Trivedi J; Silvestri NJ; Phadnis M; Katzberg HD; Saperstein DS; Wolfe GI; Herbelin L; Higgs K; Heim AJ; Statland JM; Barohn RJ; Dimachkie MM
    Eur J Neurol; 2023 May; 30(5):1417-1424. PubMed ID: 36779862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma exchange versus intravenous immunoglobulin for myasthenia gravis crisis: an acute hospital cost comparison study.
    Heatwole C; Johnson N; Holloway R; Noyes K
    J Clin Neuromuscul Dis; 2011 Dec; 13(2):85-94. PubMed ID: 22361692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.